Flupenthixol + Melitracen in pharma franchise in Karnataka

Flupenthixol + Melitracen in PCD pharma franchise in Jaipur

Flupenthixol + Melitracen in top pharma company in Agra

Flupenthixol + Melitracen in pcd pharma supplier in Rajkot

Flupenthixol + Melitracen in phama franchise company in India
Flupenthixol + Melitracen in phama distributor in Vasai-Virar

Home/Products /flupenthixol-0-point-5mg-melitracen-10mg-tablets

Flufenol M Tablet

Composition : Flupentixol (0.5mg) + Melitracen (10mg)

Dosage Form : Tablet

Packaging Type : Bister

Packaging : 10*10

Price : ₹92/-

Flufenol M Tablet is a combination medication containing Flupenthixol (0.5mg) and Melitracen (10mg), specifically designed to manage anxiety and depressive disorders. Flupenthixol, a thioxanthene derivative, functions as an antipsychotic with anxiolytic properties, helping to alleviate anxiety and agitation. Melitracen, a tricyclic antidepressant, works by restoring the balance of neurotransmitters in the brain, effectively elevating mood and reducing depressive symptoms.

This synergistic combination addresses both psychological and somatic symptoms of depression and anxiety, making it suitable for patients who experience mental and physical manifestations of these disorders. Flufenol M Tablet enhances energy levels, reduces nervous tension, and improves overall well-being, allowing patients to regain control over their daily activities. It is particularly beneficial for individuals experiencing mixed states of anxiety and depression.

The tablet provides a balanced therapeutic approach, combining rapid anxiolytic action with long-term mood stabilization. Its efficacy in managing mild to moderate psychiatric conditions makes it a reliable choice for healthcare providers aiming to offer comprehensive mental health care.

Read More

About the Product

Flufenol M Tablet is a combination medication containing Flupenthixol (0.5mg) and Melitracen (10mg), specifically designed to manage anxiety and depressive disorders. Flupenthixol, a thioxanthene derivative, functions as an antipsychotic with anxiolytic properties, helping to alleviate anxiety and agitation. Melitracen, a tricyclic antidepressant, works by restoring the balance of neurotransmitters in the brain, effectively elevating mood and reducing depressive symptoms.

This synergistic combination addresses both psychological and somatic symptoms of depression and anxiety, making it suitable for patients who experience mental and physical manifestations of these disorders. Flufenol M Tablet enhances energy levels, reduces nervous tension, and improves overall well-being, allowing patients to regain control over their daily activities. It is particularly beneficial for individuals experiencing mixed states of anxiety and depression.

The tablet provides a balanced therapeutic approach, combining rapid anxiolytic action with long-term mood stabilization. Its efficacy in managing mild to moderate psychiatric conditions makes it a reliable choice for healthcare providers aiming to offer comprehensive mental health care.

Common side effects include drowsiness, dry mouth, dizziness, and gastrointestinal discomfort. Rarely, it may cause restlessness or allergic reactions. Seek medical advice if side effects persist or worsen.

Indicated for the treatment of mild to moderate anxiety and depression.

Use only under medical supervision. Avoid alcohol during treatment. Do not stop the medication abruptly without consulting your doctor.

Store at a temperature below 30°C in a cool, dry place, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation